TABLE OF CONTENTS
1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 OVERVIEW OF GLOBAL COCHLEAR IMPLANTS MARKET 25
1.4 CURRENCY AND PRICING 25
1.5 LIMITATIONS 26
1.6 MARKETS COVERED 26
2 MARKET SEGMENTATION 28
2.1 MARKETS COVERED 28
2.2 GEOGRAPHICAL SCOPE 29
2.3 YEARS CONSIDERED FOR THE STUDY 29
2.4 DBMR TRIPOD DATA VALIDATION MODEL 30
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 33
2.6 DBMR MARKET POSITION GRID 34
2.7 VENDOR SHARE ANALYSIS 35
2.8 MULTIVARIATE MODELING 36
2.9 PRODUCTS LIFELINE CURVE 36
2.10 SECONDARY SOURCES 37
2.11 ASSUMPTIONS 37
3 EXECUTIVE SUMMARY 38
4 PREMIUM INSIGHTS 41
5 MARKET OVERVIEW 43
5.1 DRIVERS 45
5.1.1 RISING AWARENESS TOWARDS HEARING AIDS 45
5.1.2 TECHNOLOGICAL ADVANCEMENTS IN MAKING EFFICIENT DEVICES WITH INCREASED BATTERY LIFE 46
5.1.3 ADEQUATE REIMBURSEMENT SCENARIO 47
5.1.4 INCREASING NUMBER OF CASES OF HEARING LOSS 48
5.1.5 GROWING NUMBER OF HEARING AID CLINICS 52
5.2 RESTRAINTS 53
5.2.1 HIGH COST OF IMPLANTS 53
5.2.2 DEARTH OF SKILLED PROFESSIONAL 55
5.2.3 POST IMPLANTS COMPLICATIONS INCLUDING FACIAL PARALYSIS, POST-OPERATIVE SENSE OF IMBALANCE AND DAMAGE TO NERVES 55
5.3 OPPORTUNITIES 58
5.3.1 INTRODUCTION OF INNOVATIVE PRODUCT IN THE MARKET 58
5.3.2 INCREASING GOVERNMENT AND NON-GOVERNMENT INITIATIVE. 59
5.3.3 IMPROVED OUTCOMES LEADS TO EXPANSION OF INDICATION 60
5.3.4 UNMET AND UNADDRESSABLE CLINICAL NEED FOR COCHLEAR IMPLANT ACROSS THE GLOBE 60
5.4 CHALLENGES 61
5.4.1 MANUAL AND LABOR INTENSIVE PRODUCTION 61
5.4.2 NEED FOR LONG-TERM IMPLANTABLE AND RECHARGEABLE BATTERIES, CONNECTORS AND SAFETY 61
6 GLOBAL COCHLEAR IMPLANTS MARKET, BY TYPE 62
6.1 OVERVIEW 63
6.2 PRODUCT 65
6.3 ACCESSORIES 65
6.4 SOFTWARE 66
7 GLOBAL COCHLEAR IMPLANTS MARKET, BY TECHNOLOGY 67
7.1 OVERVIEW 68
7.2 ELECTRO-ACOUSTIC STIMULATION (EAS) 70
7.3 ACOUSTIC AMPLIFICATION TECHNOLOGY 71
7.4 ELECTRO-STIMULATION TECHNOLOGY 71
8 GLOBAL COCHLEAR IMPLANTS MARKET, BY AGE 72
8.1 OVERVIEW 73
8.2 ADULTS 76
8.2.1 BILATERAL IMPLANTATION 76
8.2.2 UNILATERAL IMPLANTATION 76
8.3 PEDIATRICS 77
8.3.1 BILATERAL IMPLANTATION 77
8.3.2 UNILATERAL IMPLANTATION 77
9 GLOBAL COCHLEAR IMPLANTS MARKET, BY END USER 78
9.1 OVERVIEW 79
9.2 HOSPITAL 81
9.3 ENT CLINICS 81
9.4 AMBULATORY SURGERY CENTER 82
10 GLOBAL COCHLEAR IMPLANTS MARKET, BY DISTRIBUTION CHANNEL 83
10.1 OVERVIEW 84
10.2 DIRECT 86
10.3 RETAIL 87
11 GLOBAL COCHLEAR IMPLANTS MARKET, BY GEOGRAPHY 88
11.1 OVERVIEW 89
11.2 NORTH AMERICA 94
11.2.1 U.S. 99
11.2.2 CANADA 101
11.2.3 MEXICO 103
11.3 EUROPE 105
11.3.1 GERMANY 110
11.3.2 FRANCE 112
11.3.3 U.K. 114
11.3.4 ITALY 116
11.3.5 SPAIN 118
11.3.6 SWITZERLAND 120
11.3.7 NETHERLANDS 122
11.3.8 BELGIUM 124
11.3.9 TURKEY 126
11.3.10 RUSSIA 128
11.3.11 REST OF EUROPE 130
11.4 ASIA-PACIFIC 131
11.4.1 CHINA 136
11.4.2 JAPAN 138
11.4.3 INDIA 140
11.4.4 SOUTH KOREA 142
11.4.5 AUSTRALIA 144
11.4.6 SINGAPORE 146
11.4.7 THAILAND 148
11.4.8 MALAYSIA 150
11.4.9 INDONESIA 152
11.4.10 PHILIPPINES 154
11.4.11 REST OF ASIA-PACIFIC 156
11.5 MIDDLE EAST AND AFRICA 157
11.5.1 SAUDI ARABIA 163
11.5.2 U.A.E. 165
11.5.3 SOUTH AFRICA 167
11.5.4 ISRAEL 169
11.5.5 EGYPT 171
11.5.6 REST OF MIDDLE EAST & AFRICA 173
11.6 SOUTH AMERICA 174
11.6.1 BRAZIL 179
11.6.2 ARGENTINA 181
11.6.3 REST OF SOUTH AMERICA 183
12 GLOBAL COCHLEAR IMPLANTS MARKET, COMPANY LANDSCAPE 184
12.1 COMPANY SHARE ANALYSIS: GLOBAL 184
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 185
12.3 COMPANY SHARE ANALYSIS: EUROPE 186
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 187
13 COMPANY PROFILES 188
13.1 COCHLEAR LTD. 188
13.1.1 COMPANY SNAPSHOT 188
13.1.2 REVENUE ANALYSIS 189
13.1.3 COMPANY SHARE ANALYSIS 189
13.1.4 PRODUCT PORTFOLIO 190
13.1.5 RECENT DEVELOPMENTS 190
13.2 ADVANCED BIONICS AG (A SUBSIDIARY OF SONOVA) 191
13.2.1 COMPANY SNAPSHOT 191
13.2.2 REVENUE ANALYSIS 192
13.2.3 COMPANY SHARE ANALYSIS 192
13.2.4 SOLUTION PORTFOLIO 193
13.2.5 RECENT DEVELOPMENT 193
13.3 MED-EL MEDICAL ELECTRONICS 194
13.3.1 COMPANY SNAPSHOT 194
13.3.2 COMPANY SHARE ANALYSIS 194
13.3.3 PRODUCT PORTFOLIO 194
13.3.4 RECENT DEVELOPMENTS 195
13.4 MEDTRONIC 196
13.4.1 COMPANY SNAPSHOT 196
13.4.2 REVENUE ANALYSIS 197
13.4.3 PRODUCT PORTFOLIO 197
13.4.4 RECENT DEVELOPMENT 197
13.5 NUROTRON BIOTECHNOLOGY CO. LTD. 198
13.5.1 COMPANY SNAPSHOT 198
13.5.2 PRODUCT PORTFOLIO 198
13.5.3 RECENT DEVELOPMENTS 198
13.6 OTICON A/S 199
13.6.1 COMPANY SNAPSHOT 199
13.6.2 REVENUE ANALYSIS 199
13.6.3 PRODUCT PORTFOLIO 200
13.6.4 RECENT DEVELOPMENTS 200
13.7 WIDEX A/S 201
13.7.1 COMPANY SNAPSHOT 201
13.7.2 PRODUCT PORTFOLIO 201
13.7.3 RECENT DEVELOPMENT 201
14 QUESTIONNAIRE 202
15 RELATED REPORTS 205